BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turanli B, Yildirim E, Gulfidan G, Arga KY, Sinha R. Current State of "Omics" Biomarkers in Pancreatic Cancer. J Pers Med 2021;11:127. [PMID: 33672926 DOI: 10.3390/jpm11020127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Resurreccion EP, Fong K. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites 2022;12:488. [DOI: 10.3390/metabo12060488] [Reference Citation Analysis]
2 Mogal MR, Junayed A, Mahmod MR, Sompa SA, Lima SA, Kar N, Tasminatarin, Khatun M, Zubair MA, Sikder MA, Moloney GM. A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/1617989] [Reference Citation Analysis]
3 Zhang Y, Yang J, Wang X, Li X. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Sci Rep 2021;11:20441. [PMID: 34650124 DOI: 10.1038/s41598-021-99544-x] [Reference Citation Analysis]
4 Aydin B, Caliskan A, Arga KY. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. EPMA J 2021;12:383-401. [PMID: 34567287 DOI: 10.1007/s13167-021-00246-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Arga KY, Sinha R. Recent Developments in Cancer Systems Biology: Lessons Learned and Future Directions. J Pers Med 2021;11:271. [PMID: 33916627 DOI: 10.3390/jpm11040271] [Reference Citation Analysis]